Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Feb;51(2):169-73.
doi: 10.1111/j.1365-2125.2001.01328.x.

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

Affiliations
Clinical Trial

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

S Hägg et al. Br J Clin Pharmacol. 2001 Feb.

Abstract

Aims: The study was carried out in order to assess the effects of gender and the use of oral contraceptives (OCs) on CYP2D6 and CYP2C19 activities in healthy volunteers.

Methods: Six hundred and eleven Caucasian volunteers (330 males and 281 females; age range 18-49 years) were phenotyped with respect to CYP2D6 and CYP2C19 by means of the probe drugs dextromethorphan and mephenytoin, respectively. Extensive metabolisers were selected for this study.

Results: The median dextromethorphan/dextrorphan metabolic ratio in non-OC using females was significantly lower than in males (0.067 vs 0.080; P = 0.033) (mean difference in ln dextromethorphan/dextrorphan metabolic ratio 0.023, 95% CI 0.03-0.43). For the mephenytoin S/R ratio, no such difference was observed. However, OC using females had a significantly higher median mephenytoin S/R ratio than non-OC using females (0.230 vs 0.090; P < 0.001) (mean difference in ln mephenytoin S/R ratio 0.082, 95% CI 0.60-1.04). Moreover, females using combined OCs had a significantly higher median ratio than females using OCs with progestins only (median 0.258 vs 0.135; P = 0.008) (mean difference in ln mephenytoin S/R ratio 0.82, 95% CI 0.21-1.34).

Conclusions: Given certain assumptions, the study indicates that females in the fertile age have a slightly higher CYP2D6 activity compared with males. There was no evidence of a gender difference in CYP2C19 activity. The use of combined OCs reduces the activity of CYP2C19, an effect that seems to be related to the ethinyloestradiol component.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Urinary dextromethorphan/dextrorphan ratios in 543 Caucasian volunteers between 18 and 49 years of age divided into three groups: males, non-OC using females and OC using females. The boxplot demonstrates median, interquartile range (box length) and outliers (cases with values at least 1.5 box lengths from the upper or lower edge of the box). (b) Urinary mephenytoin S/R ratios in 588 Caucasian volunteers between 18 and 49 years of age.

Similar articles

Cited by

References

    1. Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation. Clin Pharmacokin. 1995;29:169–173. - PubMed
    1. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 1995;50:222–239. - PubMed
    1. Llerena A, Cobaleda J, Martinez C, Benitez J. Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype. Eur J Drug Metab Pharmacokin. 1996;21:129–138. - PubMed
    1. Xie HG, Huang SL, Xu Z, Xiao ZS, He N, Zhou HH. Evidence for the effect of gender on activity of (S) mephenytoin 4′-hydroxylase (CYP2C19) in a Chinese population. Pharmacogenetics. 1997;7:115–119. - PubMed
    1. Tamminga WJ, Wemer J, Oosterhuis B, et al. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Eur J Clin Pharmacol. 1999;55:177–184. 10.1007/s002280050615. - DOI - PubMed

Publication types

MeSH terms